Ironwood Pharmaceuticals (NASDAQ:IRWD) Posts Quarterly Earnings Results, Misses Estimates By $0.01 EPS
One daysingle sourceOne outlet reported this, once - no second voice in this corpus.
All 1 reports on Sat, 8 August 2026
What it is about
Julie MchughIronwood PharmaceuticalUnited StatesIronwood Pharmaceuticals Company ProfileInstitutional Trading Of Ironwood PharmaceuticalsSecurities Exchange CommissionIronwood Pharmaceuticals StockNews Ratings For Ironwood Pharmaceuticals DailyEarnings History For Ironwood PharmaceuticalsAllerganCapital ManagementAmerica CorpIronwood PharmaceuticalsMarshall WaceZacks ResearchCharles Schwab Investment Management IncMillennium ManagementAmerica
Who published it, and when
How it spread - 1 original report
Sat, 8 August 2026
1 report- dailypolitical.com14:00first to report
Ironwood Pharmaceuticals (NASDAQ:IRWD – Get Free Report) posted its earnings results on Thursday. The biotechnology company reported $0.31 EPS for the quarter, missing the consensus estimate of $0.32 by ($0.01), FiscalAI reports. The company had revenue of $113.04 million for the quarter, compared to the consensus estimate of $114.84 million. Ironwood Pharmaceuticals had a net […]